Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives

被引：88
作者：
Bordet, Thierry [1 ]
Behar-Cohen, Francine [2 ,3 ,4 ,5 ]
机构：
[1] Eyevensys SAS, Paris, France
[2] INSERM, UMR S 1138, Ctr Rech Cordeliers, Team 17, Paris, France
[3] Ophtalmopole Hop Cochin, Hop Paris, AP HP, Paris, France
[4] Univ Paris 06, Sorbonne Univ, UMR S 1138, Ctr Rech Cordeliers, Paris, France
[5] Paris Descartes Univ, Sorbonne Paris Cite, UMR S 1138, Ctr Rech Cordeliers, Paris, France
来源：
DRUG DISCOVERY TODAY | 2019年 / 24卷 / 08期
关键词：
LEBER CONGENITAL AMAUROSIS; IN-VIVO; ADENOASSOCIATED VIRUS; MACULAR DEGENERATION; RETINAL DEGENERATION; DNA NANOPARTICLES; RPE65; MUTATIONS; INTRAVITREOUS INJECTION; SUBRETINAL INJECTION; LIPID NANOPARTICLES;
D O I：
10.1016/j.drudis.2019.05.038
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Ocular gene therapy has entered into clinical practice. Although viral vectors are currently the best option to replace and/or correct genes, the optimal method to deliver these treatments to the retinal pigment epithelial (RPE) cells and/or photoreceptor cells remains to be improved to increase transduction efficacy and reduce iatrogenic risks. Beyond viral-mediated gene replacement therapies, nonviral gene delivery approaches offer the promise of sustained fine-tuned expression of secreted therapeutic proteins that can be adapted to the evolving stage of the disease course and can address more common nongenetic retinal diseases, such as age-related macular degeneration (AMD). Here, we review current gene therapy strategies for ocular diseases, with a focus on clinical stage products.
引用
收藏
页码：1685 / 1693
页数：9
相关论文
共 88 条
[1]   Nanoparticle-based technologies for retinal gene therapy [J].
Adijanto, Jeffrey ;
Naash, Muna I. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 95 :353-367
[2]   Gene transfer into the mouse retina mediated by an adeno-associated viral vector [J].
Ali, RR ;
Reichel, MB ;
Thrasher, AJ ;
Levinsky, RJ ;
Kinnon, C ;
Kanuga, N ;
Hunt, DM ;
Bhattacharya, SS .
HUMAN MOLECULAR GENETICS, 1996, 5 (05) :591-594
[3]   The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited [J].
Anderson, Don H. ;
Radeke, Monte J. ;
Gallo, Natasha B. ;
Chapin, Ethan A. ;
Johnson, Patrick T. ;
Curletti, Christy R. ;
Hancox, Lisa S. ;
Hu, Jane ;
Ebright, Jessica N. ;
Malek, Goldis ;
Hauser, Michael A. ;
Rickman, Catherine Bowes ;
Bok, Dean ;
Hageman, Gregory S. ;
Johnson, Lincoln V. .
PROGRESS IN RETINAL AND EYE RESEARCH, 2010, 29 (02) :95-112
[4]  
Andrieu-Soler C, 2007, MOL VIS, V13, P692
[5]   FDA approves hereditary blindness gene therapy [J].
不详 .
NATURE BIOTECHNOLOGY, 2018, 36 (01) :6-6
[6]  
[Anonymous], 2015, EMA
[7]   Effect of gene therapy on visual function in Leber's congenital amaurosis [J].
Bainbridge, James W. B. ;
Smith, Alexander J. ;
Barker, Susie S. ;
Robbie, Scott ;
Henderson, Robert ;
Balaggan, Kamaljit ;
Viswanathan, Ananth ;
Holder, Graham E. ;
Stockman, Andrew ;
Tyler, Nick ;
Petersen-Jones, Simon ;
Bhattacharya, Shomi S. ;
Thrasher, Adrian J. ;
Fitzke, Fred W. ;
Carter, Barrie J. ;
Rubin, Gary S. ;
Moore, Anthony T. ;
Ali, Robin R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (21) :2231-2239
[8]   Ultrafast laser-assisted spatially targeted optoporation into cortical axons and retinal cells in the eye [J].
Batabyal, Subrata ;
Kim, Young-Tae ;
Mohanty, Samarendra .
JOURNAL OF BIOMEDICAL OPTICS, 2017, 22 (06)
[9]   Application of lipid nanoparticles to ocular drug delivery [J].
Battaglia, Luigi ;
Serpe, Loredana ;
Foglietta, Federica ;
Muntoni, Elisabetta ;
Gallarate, Marina ;
Del Pozo Rodriguez, Ana ;
Angeles Solinis, Maria .
EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (12) :1743-1757
[10]   Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy [J].
Bennett, J ;
Tanabe, T ;
Sun, DX ;
Zeng, Y ;
Kjeldbye, H ;
Gouras, P ;
Maguire, AM .
NATURE MEDICINE, 1996, 2 (06) :649-654
123456789